Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial

Budesonide Is More Effective Than Mesalamine or Placebo in Short-term Treatment of Collagenous Colitis

(2014) Stephan Miehlke et al.   GASTROENTEROLOGY

Risk Factors for Symptom Relapse in Collagenous Colitis After Withdrawal of Short-term Budesonide Therapy

(2013) Stephan Miehlke et al.   INFLAMMATORY BOWEL DISEASES

Microscopic colitis: Current status, present and future challenges

(2012) A. Münch et al.   Journal of Crohns & Colitis

Prednisolone and Budesonide for Short- and Long-Term Treatment of Microscopic Colitis: Systematic Review and Meta-analysis

(2011) Michael J. Stewart et al.   Clinical Gastroenterology and Hepatology

Health-related quality of life is impaired in active collagenous colitis

(2010) Henrik Hjortswang et al.   DIGESTIVE AND LIVER DISEASE

Defining clinical criteria for clinical remission and disease activity in collagenous colitis

(2009) Henrik Hjortswang et al.   INFLAMMATORY BOWEL DISEASES

Oral Budesonide for Maintenance Treatment of Collagenous Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Stephan Miehlke et al.   GASTROENTEROLOGY

Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial

(2008) O K Bonderup et al.   GUT

Short health scale: A valid, reliable, and responsive instrument for subjective health assessment in Crohnʼs disease

(2007) Henrik Stjernman et al.   INFLAMMATORY BOWEL DISEASES